Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Dry powder inhaler

Aptar Pharma launches TwisterTM, a new capsule-based Dry Powder Inhaler (DPI) specifically targeting fast-growing markets.

Hp 20229 Aptar Twister jpb
TwisterTM aims to bring cost-effective drug delivery devices to pharmaceutical companies, helping them market affordable healthcare treatment to patients worldwide.

In the U.S. and Europe, the majority of asthma drug sales are currently delivered via DPIs and pressurized Metered Dose Inhalers (pMDIs). In Asia and Latin America, asthma has been treated predominantly with pMDIs, which are considered to be a more cost-effective device proposition than DPIs. Healthcare reforms in these regions and other growing markets are making asthma diagnosis and medication more available to patients. Aptar Pharma is anticipating that the DPI growth trend will spread. TwisterTM is by nature simple to use, and will allow a wider range of asthma sufferers to not only gain better access to medication but also become more compliant with the treatment they receive due to its feedback design.

During the development process, Aptar Pharma tested and collected data on various drug formulations, validating TwisterTM as an off-the-shelf device, suitable for a variety of different drug compounds and formulations.

TwisterTM is a transparent, patient-friendly device that requires simple steps to operate--insert, twist, and inhale--and the patient will be guided by various audible and visual feedbacks confirming that the full dose has been properly delivered.

TwisterTM was developed by a global Aptar Pharma product development team. The project was initiated in France and further developed in China. It is another step forward in the global manufacturing expansion of Aptar Pharma, with molding and assembly taking place in a class ISO 7 cleanroom at the company's manufacturing facility in Suzhou (near Shanghai), China. Among the pioneers of local manufacturing in China, Aptar Pharma Suzhou was opened in 1996 and currently produces pMDI metering valves and spray pumps for the Asian market.
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report